Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2025-12-31 @ 2:15 AM
Study NCT ID:
NCT05821933
Status:
RECRUITING
Last Update Posted:
2024-04-10
First Post:
2023-03-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RC108 Combine With Furmonertinib With/Without Toripalimab in Patients With EGFR-mutated NSCLC
Sponsor:
RemeGen Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-07
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-13
First Submit QC Date:
None
Study First Post Date:
2023-04-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-09
Last Update Post Date:
2024-04-10
Last Update Post Date Type:
ACTUAL